Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
Flash glucose monitoring may improve diabetes management in Indigenous Australians
Last updated July 18, 2026
Key finding
No between-group differences were observed for change in HbA1c.
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
Clinical relevance
Understanding the effectiveness of different diabetes management strategies is crucial for improving health outcomes in Indigenous Australians, a group that faces unique health challenges. This study contributes to the ongoing evaluation of technology-based interventions in diabetes care, highlighting the need for tailored approaches that consider cultural and contextual factors.
Keep in mind
Small sample size may limit generalizability. Short duration of the study may not capture long-term effects. Potential unmeasured confounders could influence outcomes.
Published in
Journal Reference
Publication details and source links for this paper.
Audrey SE, Mariam H, Tracey H, et al. Flash glucose monitoring in Indigenous Australians with type 2 diabetes: a pilot randomized controlled trial. Pilot and Feasibility Studies. 2025;11:72. doi:10.1186/s40814-025-01607-7
Main Effects
No significant change in HbA1c levels between intervention groups.
No significant difference in percentage of time spent in target blood glucose.
No severe hypoglycaemic episodes occurred in either group.
No significant differences in EQ-5D-3L quality of life scores.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Freestyle Libre 1 FGM use, Standard care with capillary blood glucose monitoring and Blood glucose, HbA1c, Number of hypoglycaemic episodes, and 1 more.
This study contributes evidence to
Primary intervention
Freestyle Libre 1 FGM use
Primary outcomes
- Blood glucose
- HbA1c
- Number of hypoglycaemic episodes
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
8
Evidence pairs
8
Relationships
2
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 68
2
Related topics
8
Evidence pairs
555
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 8 evidence relationships
- Includes primary outcome data
- Linked to 2 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
Glycemic Control
matched_outcome
Related evidence
Evidence topic
HbA1c Reduction
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
Add to Evidence TrackerNumber of hypoglycaemic episodes
Freestyle Libre 1 FGM use → Number of hypoglycaemic episodes
Freestyle Libre 1 FGM use → Number of hypoglycaemic episodes
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerQuality of life
Freestyle Libre 1 FGM use → Quality of life
Freestyle Libre 1 FGM use → Quality of life
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerBlood glucose
Standard care with capillary blood glucose monitoring → Blood glucose
Standard care with capillary blood glucose monitoring → Blood glucose
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
Add to Evidence TrackerHbA1c
Standard care with capillary blood glucose monitoring → HbA1c
Standard care with capillary blood glucose monitoring → HbA1c
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 3 studies
Add to Evidence TrackerNumber of hypoglycaemic episodes
Standard care with capillary blood glucose monitoring → Number of hypoglycaemic episodes
Standard care with capillary blood glucose monitoring → Number of hypoglycaemic episodes
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerQuality of life
Standard care with capillary blood glucose monitoring → Quality of life
Standard care with capillary blood glucose monitoring → Quality of life
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- No between-group differences were observed for HbA1c changes.
- Percentage of time spent in target blood glucose was similar across groups.
- Quality of life scores showed no significant differences.
Who this applies to
- Indigenous Australians with type 2 diabetes.
- Adults aged 18 and older with diabetes management needs.
Keep in Mind
- Results may not apply to non-Indigenous populations.
- Findings are based on a pilot study, requiring further research.
- Cultural factors may influence diabetes management effectiveness.
Between the Lines
- Small sample size may limit generalizability.
- Short duration of the study may not capture long-term effects.
- Potential unmeasured confounders could influence outcomes.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Standard care with capillary blood glucose monitoring and HbA1c, Freestyle Libre 1 FGM use and HbA1c.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Control
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 3 studies
View evidenceDevices & Technology
Freestyle Libre 1 FGM use → HbA1c
Devices & Technology
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
View evidenceControl
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
3 studies
outcome_hubMeasures HbA1c as a key outcome.
Standard care with capillary blood glucose monitoring Evidence Hub
All studies on Standard care with capillary blood glucose monitoring
3 studies
intervention_hubContributes to Standard care with capillary blood glucose monitoring evidence base.
Freestyle Libre 1 FGM use Evidence Hub
All studies on Freestyle Libre 1 FGM use
2 studies
intervention_hubContributes to Freestyle Libre 1 FGM use evidence base.
Quality of Life Outcomes Evidence Hub
All studies measuring Quality of Life Outcomes
2 studies
outcome_hubMeasures Quality of Life Outcomes as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Standard care with capillary blood glucose monitoring and HbA1c
Intervention: Standard care with capillary blood glucose monitoringOutcome: HbA1c
3 results
All studies on Freestyle Libre 1 FGM use and HbA1c
Intervention: Freestyle Libre 1 FGM useOutcome: HbA1c
2 results
All studies on Standard care with capillary blood glucose monitoring
Intervention: Standard care with capillary blood glucose monitoring
3 results
All studies on Freestyle Libre 1 FGM use
Intervention: Freestyle Libre 1 FGM use
2 results
All studies measuring HbA1c
Outcome: HbA1c
3 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Standard care with capillary blood glucose monitoring improve HbA1c?
Strong Evidence
Standard care with capillary blood glucose monitoring may improve HbA1c.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Freestyle Libre 1 FGM use improve HbA1c?
Moderate Evidence
Freestyle Libre 1 FGM use may improve HbA1c.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: The available evidence reports mixed findings.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Standard care with capillary blood glucose monitoring improve blood glucose?
Moderate Evidence
Standard care with capillary blood glucose monitoring may improve Blood glucose.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: The available evidence reports mixed findings.
Ranked evidence signals
- 1
Blood glucose
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Standard care with capillary blood glucose monitoring improve quality of life?
Moderate Evidence
Current evidence does not show a clear benefit of Standard care with capillary blood glucose monitoring for Quality of life.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Quality of life
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
All studies on Standard care with capillary blood glucose monitoring and HbA1cAll studies on Freestyle Libre 1 FGM use and HbA1cAll studies on Standard care with capillary blood glucose monitoring and Blood glucoseAll studies on Standard care with capillary blood glucose monitoring and Quality of life
Related research
Read related research summaries.
Telemedicine improves diabetes control.Telemedicine improves glucose control in nursing home residents with diabetes.HIIT and Aerobic-Resistance Training Improve Diabetes OutcomesHRS-7535 improves glycemic control in adults with type 2 diabetesNatural products may improve glycemic control in type 2 diabetes
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.